Gary S. Ledley, MD, FSCAI | SCAI
default-headshot

Gary S. Ledley, MD, FSCAI

Professor of Medicine, Drexel University College of Medicine, St. Luke’s University Healthcare Network, Bethlehem, Pennsylvania Committee Member

Contributions

Gary S. Ledley, MD, FSCAI

HOST-EXAM Trial 10-Year Follow Up: Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy After Percutaneous Coronary Intervention—Coverage of ACC 2026

Gary S. Ledley, MD, FSCAI

Clopidogrel vs. Aspirin Monotherapy Beyond 12 Months After PCI—Coverage of CRT 2026

Gary S. Ledley, MD, FSCAI

5-Year Follow-up of the SUGAR Randomized Controlled Trial—Coverage of CRT 2026

Gary S. Ledley, MD, FSCAI

The NOBLE Left Main Revascularization Study—Coverage of TCT 2025

Gary S. Ledley, MD, FSCAI

Sex Differences in Clinical Characteristics, Management Strategy, and Outcomes of STEMI With COVID-19: NACMI Registry—Coverage of SCAI 2022 Scientific Sessions

Gary S. Ledley, MD, FSCAI

COMPLETE: Effects of Complete Revascularization on Angina-related Quality of Life in Patients With St-segment Elevation Myocardial Infarction—Coverage of ACC.22

© Society for Cardiovascular Angiography & Interventions

SCAI® is a registered trademark of the Society for Cardiovascular Angiography & Interventions.

All content found on the Society for Cardiovascular Angiography & Interventions website (www.scai.org) including text, images, audio, video, or other formats is created for informational purposes only. Links to other content are to be taken at your own risk. SCAI is not responsible for the content or claims of external websites.

Get in touch

2001 L Street NW, Suite 500 PMB50672, Washington, DC 20036
202-741-9854 TEL
800-992-7224 TOLL-FREE
800-863-5202 FAX
[email protected]

Connect

Follow us on social media.